<DOC>
	<DOCNO>NCT02893293</DOCNO>
	<brief_summary>The goal project evaluate osteonecrosis decompression surgery ferumoxytol-enhanced MRI .</brief_summary>
	<brief_title>Imaging Osteonecrosis With Ferumoxytol-Enhanced MRI</brief_title>
	<detailed_description>The goal project evaluate osteonecrosis decompression surgery ferumoxytol-enhanced MRI . The investigator approach relies FDA-approved iron supplement ferumoxytol ( Feraheme ) , use label contrast agent MRI . Ferumoxytol compose iron oxide nanoparticles , provide strong T1- T2-signal magnetic resonance ( MR ) image take cell bone marrow . 20 patient undergo MRI decompression surgery transplantation bone marrow derive cell . 10 patient receive single intravenous injection ferumoxytol prior surgery . 10 additional patient serve untreated control . The investigator hypothesize MR image intravenous injection ferumoxytol improve lesion detection allow track transplant bone marrow cell . MR image finding correlate clinical outcome .</detailed_description>
	<mesh_term>Osteonecrosis</mesh_term>
	<mesh_term>Ferrosoferric Oxide</mesh_term>
	<criteria>Osteonecrosis plan decompression surgery autologous stem cell transplant Contraindications magnetic resonance image Hemosiderosis/hemochromatosis ( patient still include nonferumoxytol arm )</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>